Zusammenfassung
Anxiolytika sind angstlösende Substanzen, wobei Benzodiazepine (BZD) die dominierende Gruppe darstellen. Sie haben einen anxiolytischen und sedierenden Effekt; deswegen werden sie auch als Tranquilizer oder Beruhigungsmittel bezeichnet. Der zusätzliche schlafinduzierende, muskelrelaxierende und antikonvulsive Effekt ist in der hier vorgestellten Indikation nicht regelhaft erwünscht.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Literatur
Billioti de Gage S, Moride Y, Ducruet T et al (2014) Benzodiazepine use and irsk of Alzheimer's disease: case-control study. BMJ 349: g5205
Bobes J, Rubio G, Terán A et al (2012) Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice. Eur Psychiatry 27(4):301–307
Fitzgerald PJ, Seemann JR, Maren S (2013) Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull 105:46–50
Gahr M, Franke B, Freudenmann RW et al (2013) Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med 7(2):147–149
Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD (2013) Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J 13(2):214–223
Ibrahim C, Naja WJ, Haddad RS (2013) Non-antidepressant pharmacologic long-term treatment of panic disorder. Curr Clin Pharmacol (Epub ahead of print)
Kasper S, Gastpar M, Müller WE et al (2014) Lavender oil preparation silexan is effective in generalized anxiety disorder - a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol 23:1–11
Liebowitz MR, Salman E, Nicolini H et al (2014) Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder. Am J Psychiatry 171(6):675–682
Lüddens H (2012) Anxiolytika und Hypnotika. In: Gründer G, Benkert O (Hrsg) Handbuch der Psychopharmakotherapie, 2. Aufl. Springer, Berlin Heidelberg New York, S 695–712
Obiora E, Hubbard R, Sanders RD, Myles PR (2013) The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax 68:163–170
Offidani E, Guidi J, Tomba E, Fava GA (2013) Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom 82(6):355–362
Pollack MH, van Ameringen M, Simon NM et al (2014) A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry 171:44–53
Yaffe K, Boustani M (2014) Benzodiazepines and risk of Alzheimer's disease. BMJ 349: g5312
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benkert, O. (2015). Anxiolytika. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-54769-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54768-3
Online ISBN: 978-3-642-54769-0
eBook Packages: Medicine (German Language)